nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB1—lung cancer	0.263	1	CbGaD
Clofazimine—ABCB11—Paclitaxel—lung cancer	0.0898	0.156	CbGbCtD
Clofazimine—ABCB11—Vinblastine—lung cancer	0.0787	0.137	CbGbCtD
Clofazimine—ABCB11—Doxorubicin—lung cancer	0.0484	0.0839	CbGbCtD
Clofazimine—ABCB1—Topotecan—lung cancer	0.0311	0.0539	CbGbCtD
Clofazimine—ABCB1—Gefitinib—lung cancer	0.0284	0.0493	CbGbCtD
Clofazimine—ABCB1—Vinorelbine—lung cancer	0.0219	0.038	CbGbCtD
Clofazimine—CYP3A4—Topotecan—lung cancer	0.0186	0.0323	CbGbCtD
Clofazimine—ABCB1—Crizotinib—lung cancer	0.0174	0.0302	CbGbCtD
Clofazimine—CYP3A4—Gefitinib—lung cancer	0.017	0.0295	CbGbCtD
Clofazimine—ABCB1—Gemcitabine—lung cancer	0.017	0.0295	CbGbCtD
Clofazimine—ABCB1—Erlotinib—lung cancer	0.0168	0.0292	CbGbCtD
Clofazimine—CYP3A4—Teniposide—lung cancer	0.0165	0.0286	CbGbCtD
Clofazimine—ABCB1—Paclitaxel—lung cancer	0.0154	0.0267	CbGbCtD
Clofazimine—ABCB1—Irinotecan—lung cancer	0.0152	0.0263	CbGbCtD
Clofazimine—ABCB1—Vinblastine—lung cancer	0.0135	0.0234	CbGbCtD
Clofazimine—CYP3A4—Vinorelbine—lung cancer	0.0131	0.0228	CbGbCtD
Clofazimine—ABCB1—Cisplatin—lung cancer	0.0124	0.0215	CbGbCtD
Clofazimine—ABCB1—Etoposide—lung cancer	0.0122	0.0211	CbGbCtD
Clofazimine—ABCB1—Docetaxel—lung cancer	0.0111	0.0193	CbGbCtD
Clofazimine—CYP3A4—Crizotinib—lung cancer	0.0104	0.0181	CbGbCtD
Clofazimine—CYP3A4—Erlotinib—lung cancer	0.0101	0.0175	CbGbCtD
Clofazimine—CYP3A4—Paclitaxel—lung cancer	0.00922	0.016	CbGbCtD
Clofazimine—CYP3A4—Irinotecan—lung cancer	0.0091	0.0158	CbGbCtD
Clofazimine—ABCB1—Doxorubicin—lung cancer	0.00829	0.0144	CbGbCtD
Clofazimine—CYP3A4—Vinblastine—lung cancer	0.00809	0.014	CbGbCtD
Clofazimine—ABCB1—Methotrexate—lung cancer	0.00803	0.0139	CbGbCtD
Clofazimine—CYP3A4—Etoposide—lung cancer	0.00729	0.0126	CbGbCtD
Clofazimine—CYP3A4—Docetaxel—lung cancer	0.00667	0.0116	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—lung cancer	0.00497	0.00862	CbGbCtD
Clofazimine—Dermatitis—Crizotinib—lung cancer	0.000371	0.00317	CcSEcCtD
Clofazimine—Diarrhoea—Pemetrexed—lung cancer	0.000368	0.00315	CcSEcCtD
Clofazimine—Anaemia—Topotecan—lung cancer	0.000366	0.00313	CcSEcCtD
Clofazimine—Diarrhoea—Gefitinib—lung cancer	0.000366	0.00313	CcSEcCtD
Clofazimine—Weight decreased—Irinotecan—lung cancer	0.000362	0.0031	CcSEcCtD
Clofazimine—Dizziness—Pemetrexed—lung cancer	0.000356	0.00304	CcSEcCtD
Clofazimine—Skin discolouration—Methotrexate—lung cancer	0.000352	0.00301	CcSEcCtD
Clofazimine—Hyperglycaemia—Gemcitabine—lung cancer	0.000352	0.00301	CcSEcCtD
Clofazimine—Nausea—Crizotinib—lung cancer	0.00035	0.00299	CcSEcCtD
Clofazimine—Jaundice—Irinotecan—lung cancer	0.000348	0.00298	CcSEcCtD
Clofazimine—Abdominal pain upper—Paclitaxel—lung cancer	0.000345	0.00295	CcSEcCtD
Clofazimine—Body temperature increased—Teniposide—lung cancer	0.000344	0.00295	CcSEcCtD
Clofazimine—Hypokalaemia—Paclitaxel—lung cancer	0.000344	0.00294	CcSEcCtD
Clofazimine—Vomiting—Pemetrexed—lung cancer	0.000342	0.00293	CcSEcCtD
Clofazimine—Vomiting—Gefitinib—lung cancer	0.00034	0.00291	CcSEcCtD
Clofazimine—Rash—Pemetrexed—lung cancer	0.000339	0.0029	CcSEcCtD
Clofazimine—Dermatitis—Pemetrexed—lung cancer	0.000339	0.0029	CcSEcCtD
Clofazimine—Rash—Gefitinib—lung cancer	0.000337	0.00288	CcSEcCtD
Clofazimine—Dermatitis—Gefitinib—lung cancer	0.000337	0.00288	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Docetaxel—lung cancer	0.00032	0.00274	CcSEcCtD
Clofazimine—Oedema—Erlotinib—lung cancer	0.000319	0.00273	CcSEcCtD
Clofazimine—Nausea—Pemetrexed—lung cancer	0.000319	0.00273	CcSEcCtD
Clofazimine—Nausea—Gefitinib—lung cancer	0.000317	0.00272	CcSEcCtD
Clofazimine—Anorexia—Vinblastine—lung cancer	0.000317	0.00271	CcSEcCtD
Clofazimine—Anaemia—Vinorelbine—lung cancer	0.000313	0.00268	CcSEcCtD
Clofazimine—Asthenia—Teniposide—lung cancer	0.000313	0.00267	CcSEcCtD
Clofazimine—Cystitis noninfective—Methotrexate—lung cancer	0.000311	0.00266	CcSEcCtD
Clofazimine—Visual impairment—Irinotecan—lung cancer	0.000309	0.00264	CcSEcCtD
Clofazimine—Pruritus—Teniposide—lung cancer	0.000308	0.00264	CcSEcCtD
Clofazimine—Anorexia—Topotecan—lung cancer	0.000308	0.00263	CcSEcCtD
Clofazimine—Cystitis—Methotrexate—lung cancer	0.000307	0.00263	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—lung cancer	0.000305	0.00261	CcSEcCtD
Clofazimine—Anorexia—Erlotinib—lung cancer	0.000305	0.00261	CcSEcCtD
Clofazimine—Photosensitivity reaction—Paclitaxel—lung cancer	0.000298	0.00255	CcSEcCtD
Clofazimine—Diarrhoea—Teniposide—lung cancer	0.000298	0.00255	CcSEcCtD
Clofazimine—Weight decreased—Paclitaxel—lung cancer	0.000296	0.00253	CcSEcCtD
Clofazimine—Hyperglycaemia—Paclitaxel—lung cancer	0.000295	0.00252	CcSEcCtD
Clofazimine—Abdominal pain upper—Docetaxel—lung cancer	0.000293	0.0025	CcSEcCtD
Clofazimine—Depression—Paclitaxel—lung cancer	0.00029	0.00249	CcSEcCtD
Clofazimine—Jaundice—Etoposide—lung cancer	0.00029	0.00248	CcSEcCtD
Clofazimine—Decreased appetite—Vinblastine—lung cancer	0.000289	0.00247	CcSEcCtD
Clofazimine—Bladder pain—Methotrexate—lung cancer	0.000288	0.00246	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—lung cancer	0.000288	0.00246	CcSEcCtD
Clofazimine—Constipation—Vinblastine—lung cancer	0.000284	0.00243	CcSEcCtD
Clofazimine—Decreased appetite—Topotecan—lung cancer	0.000281	0.0024	CcSEcCtD
Clofazimine—Visual impairment—Cisplatin—lung cancer	0.000281	0.0024	CcSEcCtD
Clofazimine—Fatigue—Topotecan—lung cancer	0.000278	0.00238	CcSEcCtD
Clofazimine—Decreased appetite—Erlotinib—lung cancer	0.000278	0.00238	CcSEcCtD
Clofazimine—Vomiting—Teniposide—lung cancer	0.000277	0.00237	CcSEcCtD
Clofazimine—Constipation—Topotecan—lung cancer	0.000276	0.00236	CcSEcCtD
Clofazimine—Fatigue—Erlotinib—lung cancer	0.000275	0.00236	CcSEcCtD
Clofazimine—Rash—Teniposide—lung cancer	0.000275	0.00235	CcSEcCtD
Clofazimine—Dermatitis—Teniposide—lung cancer	0.000274	0.00235	CcSEcCtD
Clofazimine—Constipation—Erlotinib—lung cancer	0.000273	0.00234	CcSEcCtD
Clofazimine—Headache—Teniposide—lung cancer	0.000273	0.00233	CcSEcCtD
Clofazimine—Lymphadenopathy—Methotrexate—lung cancer	0.000271	0.00232	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—lung cancer	0.000269	0.0023	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—lung cancer	0.000266	0.00228	CcSEcCtD
Clofazimine—Anorexia—Vinorelbine—lung cancer	0.000263	0.00225	CcSEcCtD
Clofazimine—Nausea—Teniposide—lung cancer	0.000259	0.00221	CcSEcCtD
Clofazimine—Anaemia—Irinotecan—lung cancer	0.000258	0.00221	CcSEcCtD
Clofazimine—Body temperature increased—Topotecan—lung cancer	0.000255	0.00218	CcSEcCtD
Clofazimine—Body temperature increased—Erlotinib—lung cancer	0.000253	0.00216	CcSEcCtD
Clofazimine—Visual impairment—Paclitaxel—lung cancer	0.000252	0.00216	CcSEcCtD
Clofazimine—Anaemia—Gemcitabine—lung cancer	0.000251	0.00215	CcSEcCtD
Clofazimine—Weight decreased—Docetaxel—lung cancer	0.000251	0.00214	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—lung cancer	0.000249	0.00213	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000245	0.00209	CcSEcCtD
Clofazimine—Jaundice—Docetaxel—lung cancer	0.000241	0.00206	CcSEcCtD
Clofazimine—Decreased appetite—Vinorelbine—lung cancer	0.00024	0.00205	CcSEcCtD
Clofazimine—Asthenia—Vinblastine—lung cancer	0.000238	0.00204	CcSEcCtD
Clofazimine—Fatigue—Vinorelbine—lung cancer	0.000238	0.00204	CcSEcCtD
Clofazimine—Constipation—Vinorelbine—lung cancer	0.000236	0.00202	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—lung cancer	0.000234	0.00201	CcSEcCtD
Clofazimine—Anaemia—Cisplatin—lung cancer	0.000234	0.002	CcSEcCtD
Clofazimine—Asthenia—Topotecan—lung cancer	0.000232	0.00198	CcSEcCtD
Clofazimine—Asthenia—Erlotinib—lung cancer	0.000229	0.00196	CcSEcCtD
Clofazimine—Pruritus—Topotecan—lung cancer	0.000228	0.00195	CcSEcCtD
Clofazimine—Oedema—Irinotecan—lung cancer	0.000228	0.00195	CcSEcCtD
Clofazimine—Diarrhoea—Vinblastine—lung cancer	0.000227	0.00195	CcSEcCtD
Clofazimine—Pruritus—Erlotinib—lung cancer	0.000226	0.00193	CcSEcCtD
Clofazimine—Oedema—Gemcitabine—lung cancer	0.000222	0.0019	CcSEcCtD
Clofazimine—Hepatitis—Docetaxel—lung cancer	0.000222	0.0019	CcSEcCtD
Clofazimine—Diarrhoea—Topotecan—lung cancer	0.000221	0.00189	CcSEcCtD
Clofazimine—Dizziness—Vinblastine—lung cancer	0.00022	0.00188	CcSEcCtD
Clofazimine—Diarrhoea—Erlotinib—lung cancer	0.000219	0.00187	CcSEcCtD
Clofazimine—Body temperature increased—Vinorelbine—lung cancer	0.000218	0.00187	CcSEcCtD
Clofazimine—Anorexia—Irinotecan—lung cancer	0.000217	0.00186	CcSEcCtD
Clofazimine—Anaemia—Etoposide—lung cancer	0.000215	0.00184	CcSEcCtD
Clofazimine—Visual impairment—Docetaxel—lung cancer	0.000214	0.00183	CcSEcCtD
Clofazimine—Dizziness—Topotecan—lung cancer	0.000214	0.00183	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000212	0.00181	CcSEcCtD
Clofazimine—Anorexia—Gemcitabine—lung cancer	0.000212	0.00181	CcSEcCtD
Clofazimine—Vomiting—Vinblastine—lung cancer	0.000211	0.00181	CcSEcCtD
Clofazimine—Dizziness—Erlotinib—lung cancer	0.000211	0.00181	CcSEcCtD
Clofazimine—Anaemia—Paclitaxel—lung cancer	0.00021	0.0018	CcSEcCtD
Clofazimine—Headache—Vinblastine—lung cancer	0.000208	0.00178	CcSEcCtD
Clofazimine—Oedema—Cisplatin—lung cancer	0.000207	0.00177	CcSEcCtD
Clofazimine—Vomiting—Topotecan—lung cancer	0.000205	0.00176	CcSEcCtD
Clofazimine—Rash—Topotecan—lung cancer	0.000204	0.00174	CcSEcCtD
Clofazimine—Dermatitis—Topotecan—lung cancer	0.000203	0.00174	CcSEcCtD
Clofazimine—Vomiting—Erlotinib—lung cancer	0.000203	0.00174	CcSEcCtD
Clofazimine—Somnolence—Irinotecan—lung cancer	0.000203	0.00173	CcSEcCtD
Clofazimine—Headache—Topotecan—lung cancer	0.000202	0.00173	CcSEcCtD
Clofazimine—Rash—Erlotinib—lung cancer	0.000201	0.00172	CcSEcCtD
Clofazimine—Dermatitis—Erlotinib—lung cancer	0.000201	0.00172	CcSEcCtD
Clofazimine—Headache—Erlotinib—lung cancer	0.0002	0.00171	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.0002	0.00171	CcSEcCtD
Clofazimine—Asthenia—Vinorelbine—lung cancer	0.000198	0.0017	CcSEcCtD
Clofazimine—Decreased appetite—Irinotecan—lung cancer	0.000198	0.00169	CcSEcCtD
Clofazimine—Eosinophilia—Methotrexate—lung cancer	0.000198	0.00169	CcSEcCtD
Clofazimine—Nausea—Vinblastine—lung cancer	0.000197	0.00169	CcSEcCtD
Clofazimine—Somnolence—Gemcitabine—lung cancer	0.000197	0.00169	CcSEcCtD
Clofazimine—Anorexia—Cisplatin—lung cancer	0.000197	0.00169	CcSEcCtD
Clofazimine—Fatigue—Irinotecan—lung cancer	0.000196	0.00168	CcSEcCtD
Clofazimine—Pruritus—Vinorelbine—lung cancer	0.000195	0.00167	CcSEcCtD
Clofazimine—Constipation—Irinotecan—lung cancer	0.000195	0.00167	CcSEcCtD
Clofazimine—Decreased appetite—Gemcitabine—lung cancer	0.000193	0.00165	CcSEcCtD
Clofazimine—Nausea—Topotecan—lung cancer	0.000192	0.00164	CcSEcCtD
Clofazimine—Fatigue—Gemcitabine—lung cancer	0.000191	0.00164	CcSEcCtD
Clofazimine—Constipation—Gemcitabine—lung cancer	0.00019	0.00162	CcSEcCtD
Clofazimine—Nausea—Erlotinib—lung cancer	0.00019	0.00162	CcSEcCtD
Clofazimine—Diarrhoea—Vinorelbine—lung cancer	0.000189	0.00162	CcSEcCtD
Clofazimine—Oedema—Paclitaxel—lung cancer	0.000186	0.00159	CcSEcCtD
Clofazimine—Dizziness—Vinorelbine—lung cancer	0.000183	0.00156	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—lung cancer	0.000183	0.00156	CcSEcCtD
Clofazimine—Photosensitivity reaction—Methotrexate—lung cancer	0.000182	0.00156	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—lung cancer	0.000182	0.00156	CcSEcCtD
Clofazimine—Anorexia—Etoposide—lung cancer	0.000181	0.00155	CcSEcCtD
Clofazimine—Body temperature increased—Irinotecan—lung cancer	0.00018	0.00154	CcSEcCtD
Clofazimine—Decreased appetite—Cisplatin—lung cancer	0.00018	0.00154	CcSEcCtD
Clofazimine—Anaemia—Docetaxel—lung cancer	0.000178	0.00153	CcSEcCtD
Clofazimine—Drowsiness—Methotrexate—lung cancer	0.000178	0.00152	CcSEcCtD
Clofazimine—Depression—Methotrexate—lung cancer	0.000177	0.00152	CcSEcCtD
Clofazimine—Anorexia—Paclitaxel—lung cancer	0.000177	0.00152	CcSEcCtD
Clofazimine—Vomiting—Vinorelbine—lung cancer	0.000176	0.0015	CcSEcCtD
Clofazimine—Body temperature increased—Gemcitabine—lung cancer	0.000175	0.0015	CcSEcCtD
Clofazimine—Rash—Vinorelbine—lung cancer	0.000174	0.00149	CcSEcCtD
Clofazimine—Dermatitis—Vinorelbine—lung cancer	0.000174	0.00149	CcSEcCtD
Clofazimine—Headache—Vinorelbine—lung cancer	0.000173	0.00148	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—lung cancer	0.000171	0.00146	CcSEcCtD
Clofazimine—Somnolence—Etoposide—lung cancer	0.000168	0.00144	CcSEcCtD
Clofazimine—Somnolence—Paclitaxel—lung cancer	0.000165	0.00141	CcSEcCtD
Clofazimine—Decreased appetite—Etoposide—lung cancer	0.000165	0.00141	CcSEcCtD
Clofazimine—Nausea—Vinorelbine—lung cancer	0.000164	0.0014	CcSEcCtD
Clofazimine—Body temperature increased—Cisplatin—lung cancer	0.000164	0.0014	CcSEcCtD
Clofazimine—Asthenia—Irinotecan—lung cancer	0.000163	0.0014	CcSEcCtD
Clofazimine—Fatigue—Etoposide—lung cancer	0.000163	0.0014	CcSEcCtD
Clofazimine—Constipation—Etoposide—lung cancer	0.000162	0.00139	CcSEcCtD
Clofazimine—Decreased appetite—Paclitaxel—lung cancer	0.000162	0.00138	CcSEcCtD
Clofazimine—Fatigue—Paclitaxel—lung cancer	0.00016	0.00137	CcSEcCtD
Clofazimine—Hepatitis—Methotrexate—lung cancer	0.00016	0.00137	CcSEcCtD
Clofazimine—Asthenia—Gemcitabine—lung cancer	0.000159	0.00136	CcSEcCtD
Clofazimine—Constipation—Paclitaxel—lung cancer	0.000159	0.00136	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000158	0.00135	CcSEcCtD
Clofazimine—Oedema—Docetaxel—lung cancer	0.000157	0.00135	CcSEcCtD
Clofazimine—Pruritus—Gemcitabine—lung cancer	0.000157	0.00134	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—lung cancer	0.000156	0.00134	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—lung cancer	0.000156	0.00133	CcSEcCtD
Clofazimine—Diarrhoea—Irinotecan—lung cancer	0.000156	0.00133	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—lung cancer	0.000154	0.00132	CcSEcCtD
Clofazimine—Visual impairment—Methotrexate—lung cancer	0.000154	0.00132	CcSEcCtD
Clofazimine—Diarrhoea—Gemcitabine—lung cancer	0.000152	0.0013	CcSEcCtD
Clofazimine—Dizziness—Irinotecan—lung cancer	0.000151	0.00129	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—lung cancer	0.00015	0.00129	CcSEcCtD
Clofazimine—Anorexia—Docetaxel—lung cancer	0.00015	0.00128	CcSEcCtD
Clofazimine—Body temperature increased—Etoposide—lung cancer	0.00015	0.00128	CcSEcCtD
Clofazimine—Asthenia—Cisplatin—lung cancer	0.000148	0.00127	CcSEcCtD
Clofazimine—Body temperature increased—Paclitaxel—lung cancer	0.000147	0.00126	CcSEcCtD
Clofazimine—Vomiting—Irinotecan—lung cancer	0.000145	0.00124	CcSEcCtD
Clofazimine—Rash—Irinotecan—lung cancer	0.000144	0.00123	CcSEcCtD
Clofazimine—Dermatitis—Irinotecan—lung cancer	0.000144	0.00123	CcSEcCtD
Clofazimine—Headache—Irinotecan—lung cancer	0.000143	0.00122	CcSEcCtD
Clofazimine—Diarrhoea—Cisplatin—lung cancer	0.000142	0.00121	CcSEcCtD
Clofazimine—Vomiting—Gemcitabine—lung cancer	0.000141	0.00121	CcSEcCtD
Clofazimine—Somnolence—Docetaxel—lung cancer	0.00014	0.0012	CcSEcCtD
Clofazimine—Rash—Gemcitabine—lung cancer	0.00014	0.0012	CcSEcCtD
Clofazimine—Dermatitis—Gemcitabine—lung cancer	0.00014	0.0012	CcSEcCtD
Clofazimine—Headache—Gemcitabine—lung cancer	0.000139	0.00119	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—lung cancer	0.000138	0.00118	CcSEcCtD
Clofazimine—Decreased appetite—Docetaxel—lung cancer	0.000137	0.00117	CcSEcCtD
Clofazimine—Asthenia—Etoposide—lung cancer	0.000136	0.00116	CcSEcCtD
Clofazimine—Fatigue—Docetaxel—lung cancer	0.000136	0.00116	CcSEcCtD
Clofazimine—Nausea—Irinotecan—lung cancer	0.000135	0.00116	CcSEcCtD
Clofazimine—Constipation—Docetaxel—lung cancer	0.000135	0.00115	CcSEcCtD
Clofazimine—Pruritus—Etoposide—lung cancer	0.000134	0.00115	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—lung cancer	0.000133	0.00114	CcSEcCtD
Clofazimine—Asthenia—Paclitaxel—lung cancer	0.000133	0.00114	CcSEcCtD
Clofazimine—Nausea—Gemcitabine—lung cancer	0.000132	0.00113	CcSEcCtD
Clofazimine—Vomiting—Cisplatin—lung cancer	0.000132	0.00113	CcSEcCtD
Clofazimine—Pruritus—Paclitaxel—lung cancer	0.000131	0.00112	CcSEcCtD
Clofazimine—Rash—Cisplatin—lung cancer	0.00013	0.00112	CcSEcCtD
Clofazimine—Dermatitis—Cisplatin—lung cancer	0.00013	0.00111	CcSEcCtD
Clofazimine—Diarrhoea—Etoposide—lung cancer	0.00013	0.00111	CcSEcCtD
Clofazimine—Anaemia—Methotrexate—lung cancer	0.000129	0.0011	CcSEcCtD
Clofazimine—Diarrhoea—Paclitaxel—lung cancer	0.000127	0.00109	CcSEcCtD
Clofazimine—Dizziness—Etoposide—lung cancer	0.000125	0.00107	CcSEcCtD
Clofazimine—Body temperature increased—Docetaxel—lung cancer	0.000124	0.00107	CcSEcCtD
Clofazimine—Dizziness—Paclitaxel—lung cancer	0.000123	0.00105	CcSEcCtD
Clofazimine—Nausea—Cisplatin—lung cancer	0.000123	0.00105	CcSEcCtD
Clofazimine—Vomiting—Etoposide—lung cancer	0.00012	0.00103	CcSEcCtD
Clofazimine—Rash—Etoposide—lung cancer	0.000119	0.00102	CcSEcCtD
Clofazimine—Dermatitis—Etoposide—lung cancer	0.000119	0.00102	CcSEcCtD
Clofazimine—Headache—Etoposide—lung cancer	0.000119	0.00102	CcSEcCtD
Clofazimine—Vomiting—Paclitaxel—lung cancer	0.000118	0.00101	CcSEcCtD
Clofazimine—Rash—Paclitaxel—lung cancer	0.000117	0.001	CcSEcCtD
Clofazimine—Dermatitis—Paclitaxel—lung cancer	0.000117	0.001	CcSEcCtD
Clofazimine—Headache—Paclitaxel—lung cancer	0.000116	0.000996	CcSEcCtD
Clofazimine—Asthenia—Docetaxel—lung cancer	0.000113	0.000967	CcSEcCtD
Clofazimine—Nausea—Etoposide—lung cancer	0.000113	0.000963	CcSEcCtD
Clofazimine—Pruritus—Docetaxel—lung cancer	0.000111	0.000953	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—lung cancer	0.000111	0.000952	CcSEcCtD
Clofazimine—Nausea—Paclitaxel—lung cancer	0.00011	0.000944	CcSEcCtD
Clofazimine—Anorexia—Methotrexate—lung cancer	0.000108	0.000926	CcSEcCtD
Clofazimine—Diarrhoea—Docetaxel—lung cancer	0.000108	0.000922	CcSEcCtD
Clofazimine—Dizziness—Docetaxel—lung cancer	0.000104	0.000891	CcSEcCtD
Clofazimine—Somnolence—Methotrexate—lung cancer	0.000101	0.000863	CcSEcCtD
Clofazimine—Vomiting—Docetaxel—lung cancer	0.0001	0.000857	CcSEcCtD
Clofazimine—Rash—Docetaxel—lung cancer	9.93e-05	0.000849	CcSEcCtD
Clofazimine—Dermatitis—Docetaxel—lung cancer	9.92e-05	0.000849	CcSEcCtD
Clofazimine—Decreased appetite—Methotrexate—lung cancer	9.87e-05	0.000844	CcSEcCtD
Clofazimine—Headache—Docetaxel—lung cancer	9.87e-05	0.000844	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—lung cancer	9.83e-05	0.000841	CcSEcCtD
Clofazimine—Fatigue—Methotrexate—lung cancer	9.79e-05	0.000837	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—lung cancer	9.37e-05	0.000802	CcSEcCtD
Clofazimine—Nausea—Docetaxel—lung cancer	9.35e-05	0.0008	CcSEcCtD
Clofazimine—Body temperature increased—Methotrexate—lung cancer	8.97e-05	0.000768	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—lung cancer	8.74e-05	0.000748	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—lung cancer	8.54e-05	0.000731	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—lung cancer	8.47e-05	0.000725	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—lung cancer	8.4e-05	0.000719	CcSEcCtD
Clofazimine—Asthenia—Methotrexate—lung cancer	8.14e-05	0.000697	CcSEcCtD
Clofazimine—Pruritus—Methotrexate—lung cancer	8.03e-05	0.000687	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—lung cancer	7.77e-05	0.000665	CcSEcCtD
Clofazimine—Diarrhoea—Methotrexate—lung cancer	7.77e-05	0.000664	CcSEcCtD
Clofazimine—Dizziness—Methotrexate—lung cancer	7.51e-05	0.000642	CcSEcCtD
Clofazimine—Vomiting—Methotrexate—lung cancer	7.22e-05	0.000617	CcSEcCtD
Clofazimine—Rash—Methotrexate—lung cancer	7.16e-05	0.000612	CcSEcCtD
Clofazimine—Dermatitis—Methotrexate—lung cancer	7.15e-05	0.000612	CcSEcCtD
Clofazimine—Headache—Methotrexate—lung cancer	7.11e-05	0.000608	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—lung cancer	7.05e-05	0.000603	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—lung cancer	6.95e-05	0.000595	CcSEcCtD
Clofazimine—CYP3A4—Biological oxidations—GSTA3—lung cancer	6.76e-05	0.00157	CbGpPWpGaD
Clofazimine—Nausea—Methotrexate—lung cancer	6.74e-05	0.000577	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—lung cancer	6.72e-05	0.000575	CcSEcCtD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	6.66e-05	0.00155	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CNDP2—lung cancer	6.51e-05	0.00151	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTM2—lung cancer	6.51e-05	0.00151	CbGpPWpGaD
Clofazimine—Dizziness—Doxorubicin—lung cancer	6.5e-05	0.000556	CcSEcCtD
Clofazimine—ABCB11—Metabolism—MTMR3—lung cancer	6.33e-05	0.00147	CbGpPWpGaD
Clofazimine—Vomiting—Doxorubicin—lung cancer	6.25e-05	0.000535	CcSEcCtD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	6.25e-05	0.00145	CbGpPWpGaD
Clofazimine—Rash—Doxorubicin—lung cancer	6.2e-05	0.00053	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—lung cancer	6.19e-05	0.00053	CcSEcCtD
Clofazimine—CYP3A4—Biological oxidations—GSTA4—lung cancer	6.18e-05	0.00143	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PGAM1—lung cancer	6.17e-05	0.00143	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	6.16e-05	0.00143	CbGpPWpGaD
Clofazimine—Headache—Doxorubicin—lung cancer	6.16e-05	0.000527	CcSEcCtD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	6.11e-05	0.00142	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	6.09e-05	0.00141	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTA2—lung cancer	6.02e-05	0.0014	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CASP8—lung cancer	5.94e-05	0.00138	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP2A7—lung cancer	5.89e-05	0.00137	CbGpPWpGaD
Clofazimine—Nausea—Doxorubicin—lung cancer	5.84e-05	0.000499	CcSEcCtD
Clofazimine—CYP3A4—Biological oxidations—GSTA1—lung cancer	5.81e-05	0.00135	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	5.79e-05	0.00134	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—SDC4—lung cancer	5.76e-05	0.00134	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	5.68e-05	0.00132	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	5.49e-05	0.00127	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	5.49e-05	0.00127	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—UGT1A1—lung cancer	5.4e-05	0.00125	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	5.33e-05	0.00124	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—RRM1—lung cancer	5.25e-05	0.00122	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA3—lung cancer	5.25e-05	0.00122	CbGpPWpGaD
Clofazimine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	5.14e-05	0.00119	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	5.06e-05	0.00117	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	5.04e-05	0.00117	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	4.98e-05	0.00116	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—B4GALT5—lung cancer	4.93e-05	0.00114	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA4—lung cancer	4.8e-05	0.00111	CbGpPWpGaD
Clofazimine—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	4.77e-05	0.00111	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CXCL8—lung cancer	4.69e-05	0.00109	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.69e-05	0.00109	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA2—lung cancer	4.68e-05	0.00109	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	4.66e-05	0.00108	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	4.65e-05	0.00108	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—HPGDS—lung cancer	4.59e-05	0.00107	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA1—lung cancer	4.51e-05	0.00105	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CASP3—lung cancer	4.49e-05	0.00104	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL2—lung cancer	4.48e-05	0.00104	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCC3—lung cancer	4.46e-05	0.00104	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTT1—lung cancer	4.45e-05	0.00103	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GCLC—lung cancer	4.4e-05	0.00102	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP2A6—lung cancer	4.4e-05	0.00102	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	4.4e-05	0.00102	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—AKR1C1—lung cancer	4.32e-05	0.001	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	4.28e-05	0.000994	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—UGT1A1—lung cancer	4.2e-05	0.000973	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GNG11—lung cancer	4.05e-05	0.000938	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.02e-05	0.000934	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	3.94e-05	0.000913	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALDOA—lung cancer	3.85e-05	0.000894	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—AZIN2—lung cancer	3.84e-05	0.000891	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—COL4A3BP—lung cancer	3.84e-05	0.000891	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—VEGFA—lung cancer	3.81e-05	0.000884	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	3.78e-05	0.000876	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	3.74e-05	0.000869	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—NCOA3—lung cancer	3.74e-05	0.000867	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	3.69e-05	0.000857	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.67e-05	0.000852	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ADCY1—lung cancer	3.64e-05	0.000844	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCG2—lung cancer	3.64e-05	0.000844	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.62e-05	0.000841	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—HPGDS—lung cancer	3.57e-05	0.000828	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ENO2—lung cancer	3.57e-05	0.000828	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPP2R1B—lung cancer	3.54e-05	0.000822	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.5e-05	0.000811	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTT1—lung cancer	3.46e-05	0.000803	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GCLC—lung cancer	3.42e-05	0.000793	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP2A6—lung cancer	3.42e-05	0.000793	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.41e-05	0.00079	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	3.4e-05	0.00079	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ATP5H—lung cancer	3.27e-05	0.000758	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ENO1—lung cancer	3.24e-05	0.000752	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.23e-05	0.000749	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.19e-05	0.00074	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.14e-05	0.00073	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.11e-05	0.000721	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.09e-05	0.000716	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	3.09e-05	0.000716	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.05e-05	0.000706	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.93e-05	0.000679	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.92e-05	0.000676	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PLBD1—lung cancer	2.91e-05	0.000675	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP2E1—lung cancer	2.91e-05	0.000675	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—NQO1—lung cancer	2.88e-05	0.000667	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.84e-05	0.000658	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.82e-05	0.000653	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.81e-05	0.000651	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.8e-05	0.000649	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.79e-05	0.000647	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.78e-05	0.000646	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.78e-05	0.000644	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.78e-05	0.000644	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.69e-05	0.000624	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HSD17B10—lung cancer	2.66e-05	0.000618	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.65e-05	0.000615	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—STK11—lung cancer	2.59e-05	0.000601	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.58e-05	0.000599	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.48e-05	0.000575	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CKB—lung cancer	2.47e-05	0.000574	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.47e-05	0.000573	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.44e-05	0.000566	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.43e-05	0.000564	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTP1—lung cancer	2.4e-05	0.000556	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.39e-05	0.000554	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.37e-05	0.000549	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—AZIN2—lung cancer	2.37e-05	0.000549	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CAT—lung cancer	2.33e-05	0.000541	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CNDP2—lung cancer	2.33e-05	0.00054	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTM2—lung cancer	2.33e-05	0.00054	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.32e-05	0.000538	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCB1—lung cancer	2.27e-05	0.000527	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—MTMR3—lung cancer	2.26e-05	0.000525	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—TYMS—lung cancer	2.23e-05	0.000517	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.22e-05	0.000514	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PGAM1—lung cancer	2.21e-05	0.000512	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTM1—lung cancer	2.2e-05	0.000511	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.16e-05	0.0005	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.15e-05	0.000499	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP2A7—lung cancer	2.1e-05	0.000488	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP1A1—lung cancer	2.09e-05	0.000485	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.09e-05	0.000484	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.08e-05	0.000483	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ERCC2—lung cancer	2.07e-05	0.000481	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—SDC4—lung cancer	2.06e-05	0.000478	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ATP5H—lung cancer	2.01e-05	0.000467	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—POMC—lung cancer	2.01e-05	0.000465	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.99e-05	0.000461	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.93e-05	0.000448	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.88e-05	0.000436	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA3—lung cancer	1.88e-05	0.000435	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—RRM1—lung cancer	1.88e-05	0.000435	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PLBD1—lung cancer	1.79e-05	0.000416	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOA1—lung cancer	1.79e-05	0.000416	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.79e-05	0.000415	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.78e-05	0.000413	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—B4GALT5—lung cancer	1.76e-05	0.000409	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.73e-05	0.000401	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.72e-05	0.000398	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA4—lung cancer	1.72e-05	0.000398	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.69e-05	0.000393	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA2—lung cancer	1.67e-05	0.000388	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HSD17B10—lung cancer	1.64e-05	0.00038	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CG—lung cancer	1.64e-05	0.00038	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA1—lung cancer	1.61e-05	0.000374	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.6e-05	0.000371	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ABCC3—lung cancer	1.59e-05	0.00037	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—POMC—lung cancer	1.56e-05	0.000361	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—AKR1C1—lung cancer	1.54e-05	0.000358	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CKB—lung cancer	1.52e-05	0.000354	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CREBBP—lung cancer	1.52e-05	0.000352	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—UGT1A1—lung cancer	1.5e-05	0.000348	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.47e-05	0.000341	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GNG11—lung cancer	1.45e-05	0.000335	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CD—lung cancer	1.44e-05	0.000334	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTM2—lung cancer	1.43e-05	0.000333	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CNDP2—lung cancer	1.43e-05	0.000333	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.42e-05	0.00033	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALB—lung cancer	1.42e-05	0.000329	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—MTMR3—lung cancer	1.39e-05	0.000324	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALDOA—lung cancer	1.38e-05	0.000319	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.37e-05	0.000317	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PGAM1—lung cancer	1.36e-05	0.000315	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—NCOA3—lung cancer	1.34e-05	0.00031	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ADCY1—lung cancer	1.3e-05	0.000302	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ABCG2—lung cancer	1.3e-05	0.000302	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.3e-05	0.000301	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HPGDS—lung cancer	1.27e-05	0.000296	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ENO2—lung cancer	1.27e-05	0.000296	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—SDC4—lung cancer	1.27e-05	0.000294	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPP2R1B—lung cancer	1.27e-05	0.000294	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CB—lung cancer	1.25e-05	0.000291	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PTGS2—lung cancer	1.24e-05	0.000288	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTT1—lung cancer	1.24e-05	0.000287	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP2A6—lung cancer	1.22e-05	0.000284	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GCLC—lung cancer	1.22e-05	0.000284	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.2e-05	0.000278	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ENO1—lung cancer	1.16e-05	0.000269	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.16e-05	0.000269	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—RRM1—lung cancer	1.16e-05	0.000268	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA3—lung cancer	1.16e-05	0.000268	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.09e-05	0.000252	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.08e-05	0.000251	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PTEN—lung cancer	1.08e-05	0.000251	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA4—lung cancer	1.06e-05	0.000245	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP2E1—lung cancer	1.04e-05	0.000241	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—EP300—lung cancer	1.03e-05	0.00024	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA2—lung cancer	1.03e-05	0.000239	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—NQO1—lung cancer	1.03e-05	0.000238	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA1—lung cancer	9.94e-06	0.000231	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCC3—lung cancer	9.82e-06	0.000228	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.8e-06	0.000227	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—AKR1C1—lung cancer	9.52e-06	0.000221	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—STK11—lung cancer	9.26e-06	0.000215	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—UGT1A1—lung cancer	9.24e-06	0.000214	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GNG11—lung cancer	8.91e-06	0.000207	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTP1—lung cancer	8.57e-06	0.000199	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALDOA—lung cancer	8.48e-06	0.000197	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CAT—lung cancer	8.34e-06	0.000193	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—NCOA3—lung cancer	8.23e-06	0.000191	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ADCY1—lung cancer	8.01e-06	0.000186	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCG2—lung cancer	8.01e-06	0.000186	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—TYMS—lung cancer	7.97e-06	0.000185	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTM1—lung cancer	7.88e-06	0.000183	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ENO2—lung cancer	7.85e-06	0.000182	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HPGDS—lung cancer	7.85e-06	0.000182	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.81e-06	0.000181	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CA—lung cancer	7.64e-06	0.000177	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTT1—lung cancer	7.62e-06	0.000177	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GCLC—lung cancer	7.53e-06	0.000175	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP2A6—lung cancer	7.53e-06	0.000175	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP1A1—lung cancer	7.47e-06	0.000173	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ERCC2—lung cancer	7.41e-06	0.000172	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ENO1—lung cancer	7.14e-06	0.000166	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOA1—lung cancer	6.41e-06	0.000149	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.4e-06	0.000149	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—NQO1—lung cancer	6.33e-06	0.000147	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—AKT1—lung cancer	6.24e-06	0.000145	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CG—lung cancer	5.85e-06	0.000136	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—STK11—lung cancer	5.71e-06	0.000132	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—POMC—lung cancer	5.57e-06	0.000129	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CREBBP—lung cancer	5.42e-06	0.000126	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTP1—lung cancer	5.28e-06	0.000122	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CD—lung cancer	5.14e-06	0.000119	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CAT—lung cancer	5.14e-06	0.000119	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALB—lung cancer	5.08e-06	0.000118	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCB1—lung cancer	5e-06	0.000116	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—TYMS—lung cancer	4.91e-06	0.000114	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTM1—lung cancer	4.85e-06	0.000113	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.6e-06	0.000107	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ERCC2—lung cancer	4.56e-06	0.000106	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CB—lung cancer	4.48e-06	0.000104	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PTGS2—lung cancer	4.44e-06	0.000103	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOA1—lung cancer	3.95e-06	9.16e-05	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PTEN—lung cancer	3.87e-06	8.98e-05	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—EP300—lung cancer	3.69e-06	8.57e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.6e-06	8.36e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—POMC—lung cancer	3.43e-06	7.96e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CREBBP—lung cancer	3.34e-06	7.75e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.17e-06	7.35e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALB—lung cancer	3.13e-06	7.25e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.76e-06	6.4e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PTGS2—lung cancer	2.74e-06	6.35e-05	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CA—lung cancer	2.73e-06	6.34e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PTEN—lung cancer	2.39e-06	5.53e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—EP300—lung cancer	2.28e-06	5.28e-05	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—AKT1—lung cancer	2.23e-06	5.18e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.68e-06	3.9e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—AKT1—lung cancer	1.37e-06	3.19e-05	CbGpPWpGaD
